Genscript
GenScript is an international biotechnology company and Contract Research Organisation (CRO) established in 2002 in Piscataway USA. It is globally recognised as a one of the world’s leading specialists in fundamental life sciences research and early-phase drug discovery services.
The company has a comprehensive range of high-quality antibodies - Primary Antibodies and Secondary Antibodies. Along with these GenScript has a variety of recombinant proteins including Cytokines, Chemokines, Growth Factors, Hormones etc. Allied to this, GenScript has many high-quality molecular biology reagents, including its fast and reliable DNA purification and analysis products.
Immune Checkpoint Stable Cell Lines
Inhibitors of immune-checkpoint proteins, such as PD1, PD-L1, VISTA, Tim3 and Lag3, have indicated broad and diverse opportunities to increase antitumor immunity by enhancing T cell activity with the potential to produce durable clinical responses.
To meet these needs, we have developed stable cell line products expressing the most popular immune checkpoints to accelerate your immunotherapy drug discovery and achieve US Food and Drug Administration (FDA) approval. All these stable cells are developed for screening high affinity antibodies against immune checkpoint proteins.
Key features
- High protein expression at the cell surface validated by FACS
- Stable cell lines for increased reliability and reproducibility (over 15 passages)
- Ready to use hot targets, saving 3-5 months of drug discovery program
